Your position:
www.healthoo.com
>>
EN
>>
EN
>>
Formulation
>>
US FDA grants orphan drug designation to Zenith Epigenetics’ ZEN-3694 to treat NUT carcinoma
>> article
US FDA grants orphan drug designation to Zenith Epigenetics’ ZEN-3694 to treat NUT carcinoma
Editor:xuezhe Clicks:
0
Date:2025/10/29 15:03:52
Keyword:
US FDA
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68012929
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Imipenem parent nucleus reference price
Imipenem parent nucleus reference price
Major vitamin products are included in the US tariff exemption list.
Big Pharma Faces Threat as US-EU Tariff Dispute Puts Best-Selling Drug...
FDA plans to cancel the Self-GRAS certification, and synthetic biologi...
Imipenem parent nucleus reference price
Jan Aushadhi Kendras report 36.7% growth in sales in May
Genetic Signatures’ EasyScreen gastrointestinal parasite detection kit...
Adicet Bio receives US FDA fast track designation for ADI-001 for clas...
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
